Reproductive and Hormonal Factors and Lung Cancer Risk in the NIH-AARP Diet and Health Study Cohort

被引:61
作者
Brinton, Louise A. [1 ]
Gierach, Gretchen L.
Andaya, Abegail
Park, Yikyung
Schatzkin, Arthur
Hollenbeck, Albert R. [2 ]
Spitz, Margaret R. [3 ,4 ]
机构
[1] NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD 20852 USA
[2] AARP, Washington, DC USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Baylor Coll Med, Houston, TX 77030 USA
关键词
REPLACEMENT THERAPY; CHINESE-WOMEN; POSTMENOPAUSAL WOMEN; SEX-DIFFERENCES; NURSES HEALTH; ESTROGEN; SMOKING; ADENOCARCINOMA; ASSOCIATION; PRACTITIONERS;
D O I
10.1158/1055-9965.EPI-10-1325
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Lung cancer exhibits unique patterns among women including high adenocarcinoma rates among nonsmokers. Inconsistent findings about hormonal factors on risk may reflect incomplete control for confounding, misclassification of exposures, or insufficient attention to variation by histology. Methods: Among 185,017 women, ages 50 to 71 years, recruited during 1995 and 1996 for the NIH-AARP (American Association of Retired Persons) Diet and Health Study, we identified 3,512 incident lung cancers (including 276 in never smokers) in follow-up through December 2006. Multivariable Cox proportional hazards models estimated relative risks (RR) and 95% CIs for self-reported hormonally related risk factors. Results: After adjustment for smoking and other confounders, subjects with late menarche were at reduced risk, with the association specific for adenocarcinomas (RR = 0.72 for menarche 15+ vs. < 11, P(trend) < 0.01). Subjects with early ages at ovarian cessation (either from natural menopause or bilateral oophorectomy) were at an increased risk for adenocarcinomas and squamous cell tumors, but the associations were strongest for smokers, suggesting either residual confounding or an enhanced effect of menopausally related factors among subjects with decreased endogenous estrogens. In contrast, we saw no relationships of risk with either parity, age at first birth, or exogenous hormone use. Conclusions: Elevated levels of hormones may adversely affect lung function early in life while assisting with cellular and immunologic responses later in life. Additional attention toward the role of hormonal factors may further our understanding of lung carcinogenesis. Impact: Our findings provide some support for a role of hormonal factors in the etiology of lung cancer, although the mechanisms appear complicated. Cancer Epidemiol Biomarkers Prev; 20(5); 900-11. (C)2011 AACR.
引用
收藏
页码:900 / 911
页数:12
相关论文
共 50 条
[1]   RISK OF CANCER IN WOMEN RECEIVING HORMONE REPLACEMENT THERAPY [J].
ADAMI, HO ;
PERSSON, I ;
HOOVER, R ;
SCHAIRER, C ;
BERGKVIST, L .
INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (05) :833-839
[2]   Reproductive Factors, Hormone Use, and Risk for Lung Cancer in Postmenopausal Women, the Nurses' Health Study [J].
Baik, Christina S. ;
Strauss, Gary M. ;
Speizer, Frank E. ;
Feskanich, Diane .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (10) :2525-2533
[3]  
Beral V, 2005, LANCET, V365, P1543, DOI 10.1016/S0140-6736(05)66455-0
[4]   Sex differences and estrogen modulation of the cellular immune response after injury [J].
Bird, Melanie D. ;
Karavitis, John ;
Kovacs, Elizabeth J. .
CELLULAR IMMUNOLOGY, 2008, 252 (1-2) :57-67
[5]   Estrogen replacement therapy and risk of lung cancer [J].
Blackman, JA ;
Coogan, PF ;
Rosenberg, L ;
Strom, BL ;
Zauber, AG ;
Palmer, JR ;
Langenberg, P ;
Shapiro, S .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2002, 11 (07) :561-567
[6]   Menstrual and reproductive factors and risk of lung cancer among Chinese women, Eastern Gansu Province, 1994-1998 [J].
Brenner, AV ;
Wang, ZY ;
Kleinerman, RA ;
Lei, SJ ;
Metayer, C ;
Wang, WL ;
Lubin, JH .
JOURNAL OF EPIDEMIOLOGY, 2003, 13 (01) :22-28
[7]   Menopausal Hormone Therapy and Breast Cancer Risk in the NIH-AARP Diet and Health Study Cohort [J].
Brinton, Louise A. ;
Richesson, Douglas ;
Leitzmann, Michael F. ;
Gierach, Gretchen L. ;
Schatzkin, Arthur ;
Mouw, Traci ;
Hollenbeck, Albert R. ;
Lacey, James V., Jr. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (11) :3150-3160
[8]   Asthma and risk of death from lung cancer: NHANES II mortality study [J].
Brown, DW ;
Young, KE ;
Anda, RF ;
Giles, WH .
JOURNAL OF ASTHMA, 2005, 42 (07) :597-600
[9]   Hormone replacement therapy and lung cancer risk in Chinese [J].
Chen, Kuan-Yu ;
Hsiao, Chin-Fu ;
Chang, Gee-Chen ;
Tsai, Yin-Huang ;
Su, Wu-Chou ;
Perng, Reury-Perng ;
Huang, Ming-Shyan ;
Hsiung, Chao A. ;
Chen, Chien-Jen ;
Yang, Pan-Chyr .
CANCER, 2007, 110 (08) :1768-1775
[10]   Lung Cancer Among Postmenopausal Women Treated With Estrogen Alone in the Women's Health Initiative Randomized Trial [J].
Chlebowski, Rowan T. ;
Anderson, Garnet L. ;
Manson, JoAnn E. ;
Schwartz, Ann G. ;
Wakelee, Heather ;
Gass, Margery ;
Rodabough, Rebecca J. ;
Johnson, Karen C. ;
Wactawski-Wende, Jean ;
Kotchen, Jane Morley ;
Ockene, Judith K. ;
O'Sullivan, Mary Jo ;
Hubbell, F. Allan ;
Chien, Jason W. ;
Chen, Chu ;
Stefanick, Marcia L. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (18) :1413-1421